Jiajin Liu
Papers
1
Total Citations
19
H-Index
1
About
Dr. Jiajin Liu is a pioneering urologic oncologist whose research is reshaping the diagnostic and surgical paradigms for prostate cancer. His work centers on advancing precision medicine through the integration of cutting-edge imaging, specifically combining <sup>18</sup>F-labeled PSMA PET/CT with multiparametric MRI, to guide clinical decision-making. Dr. Liu’s most notable contribution is his landmark 2024 single-center, prospective trial, which boldly challenged the standard of care by investigating the feasibility of performing radical prostatectomy without a prior biopsy in highly selected patients. This study, which has already garnered 19 citations, demonstrated that a non-invasive, imaging-based diagnosis could accurately identify candidates for surgery, potentially sparing patients from the risks and discomfort of an invasive biopsy. By proposing a paradigm shift towards a "biopsy-avoiding" pathway, Dr. Liu’s work has significant implications for reducing overtreatment and streamlining the patient journey. His research is at the forefront of a new era in urologic oncology, where advanced imaging may one day replace traditional histopathological confirmation for select surgical candidates.
Research Focus
Key Achievements
Top Papers
- 1